Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Total article views   Abstract views HTML views PDF downloads Totals
8,388 Dovepress* 6,064 1,011+ 1,318 7,075
PubMed Central* 0 1,313 364 1,313
Totals 6,064 2,324 1,682 8,388
*Since 3 August 2017
+Since July 2016

View citations on PubMed Central and Google Scholar